Valetudo Therapeutics LLC 13D and 13G filings for Liminatus Pharma, Inc. Class A Common Stock:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-05-07 5:11 pm Purchase | 2025-04-30 | 13D | Liminatus Pharma, Inc. Class A Common Stock LIMN | Valetudo Therapeutics LLC | 6,169,406 23.700% | 6,169,406 (New Position) | Filing |